138 related articles for article (PubMed ID: 27424896)
1. Bioluminescent Ligand-Receptor Binding Assays for Protein or Peptide Hormones.
Liu YL; Guo ZY
Methods Mol Biol; 2016; 1461():65-90. PubMed ID: 27424896
[TBL] [Abstract][Full Text] [Related]
2. Novel bioluminescent binding assays for interaction studies of protein/peptide hormones with their receptors.
Liu YL; Guo ZY
Amino Acids; 2016 May; 48(5):1151-60. PubMed ID: 27020777
[TBL] [Abstract][Full Text] [Related]
3. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
[TBL] [Abstract][Full Text] [Related]
4. Quick preparation of nanoluciferase-based tracers for novel bioluminescent receptor-binding assays of protein hormones: Using erythropoietin as a model.
Song G; Wu QP; Xu T; Liu YL; Xu ZG; Zhang SF; Guo ZY
J Photochem Photobiol B; 2015 Dec; 153():311-6. PubMed ID: 26506452
[TBL] [Abstract][Full Text] [Related]
5. Novel bioluminescent receptor-binding assays for peptide hormones: using ghrelin as a model.
Liu Y; Shao XX; Zhang L; Song G; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2015 Oct; 47(10):2237-43. PubMed ID: 26002812
[TBL] [Abstract][Full Text] [Related]
6. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
7. Application of the novel bioluminescent ligand-receptor binding assay to relaxin-RXFP1 system for interaction studies.
Wu QP; Zhang L; Shao XX; Wang JH; Gao Y; Xu ZG; Liu YL; Guo ZY
Amino Acids; 2016 Apr; 48(4):1099-1107. PubMed ID: 26767372
[TBL] [Abstract][Full Text] [Related]
8. Quantitative measurement of cell membrane receptor internalization by the nanoluciferase reporter: Using the G protein-coupled receptor RXFP3 as a model.
Liu Y; Song G; Shao XX; Liu YL; Guo ZY
Biochim Biophys Acta; 2015 Feb; 1848(2):688-94. PubMed ID: 25434927
[TBL] [Abstract][Full Text] [Related]
9. A novel ultrasensitive bioluminescent receptor-binding assay of INSL3 through chemical conjugation with nanoluciferase.
Zhang L; Song G; Xu T; Wu QP; Shao XX; Liu YL; Xu ZG; Guo ZY
Biochimie; 2013 Dec; 95(12):2454-9. PubMed ID: 24056075
[TBL] [Abstract][Full Text] [Related]
10. A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.
Wang JH; Shao XX; Hu MJ; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 May; 49(5):895-903. PubMed ID: 28161795
[TBL] [Abstract][Full Text] [Related]
11. Novel Bioluminescent Binding Assays for Ligand-Receptor Interaction Studies of the Fibroblast Growth Factor Family.
Song G; Shao XX; Wu QP; Xu ZG; Liu YL; Guo ZY
PLoS One; 2016; 11(7):e0159263. PubMed ID: 27414797
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
13. The luminescent HiBiT peptide enables selective quantitation of G protein-coupled receptor ligand engagement and internalization in living cells.
Boursier ME; Levin S; Zimmerman K; Machleidt T; Hurst R; Butler BL; Eggers CT; Kirkland TA; Wood KV; Friedman Ohana R
J Biol Chem; 2020 Apr; 295(15):5124-5135. PubMed ID: 32107310
[TBL] [Abstract][Full Text] [Related]
14. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
[TBL] [Abstract][Full Text] [Related]
15. A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity.
Ahmed WS; Geethakumari AM; Sultana A; Fatima A; Philip AM; Uddin SMN; Biswas KH
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131864. PubMed ID: 38692549
[TBL] [Abstract][Full Text] [Related]
16. A general method for quantifying ligand binding to unmodified receptors using Gaussia luciferase.
Tóth AD; Garger D; Prokop S; Soltész-Katona E; Várnai P; Balla A; Turu G; Hunyady L
J Biol Chem; 2021; 296():100366. PubMed ID: 33545176
[TBL] [Abstract][Full Text] [Related]
17. The NanoBiT-Based Homogenous Ligand-Receptor Binding Assay.
Liu YL; Guo ZY
Methods Mol Biol; 2022; 2525():139-153. PubMed ID: 35836065
[TBL] [Abstract][Full Text] [Related]
18. An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.
Killoran MP; Levin S; Boursier ME; Zimmerman K; Hurst R; Hall MP; Machleidt T; Kirkland TA; Friedman Ohana R
Molecules; 2021 May; 26(10):. PubMed ID: 34065854
[TBL] [Abstract][Full Text] [Related]
19. Identification of Factors Complicating Bioluminescence Imaging.
Yeh HW; Wu T; Chen M; Ai HW
Biochemistry; 2019 Mar; 58(12):1689-1697. PubMed ID: 30810040
[TBL] [Abstract][Full Text] [Related]
20. [Bioluminescent imaging: applications to cancerology and endocrinology].
Pillon A; Gauthier P; Balaguer P; Pélegrin A; Nicolas JC
J Soc Biol; 2004; 198(2):157-61. PubMed ID: 15368967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
